Literature DB >> 29515243

Reply to Lambros et al.

Zhenya Tang1, Jianjun Zhang2, Hui Chen3, Selina Lu1, Joanne Cheng1, Guilin Tang1, L Jeffrey Medeiros1.   

Abstract

Mesh：

Year:  2018        PMID： 29515243     DOI： 10.1038/modpathol.2017.192

Source DB:  PubMed          Journal:  Mod Pathol        ISSN： 0893-3952            Impact factor:   7.842


× No keyword cloud information.
  8 in total

1.  Coexistent genetic alterations involving ALK, RET, ROS1 or MET in 15 cases of lung adenocarcinoma.

Authors:  Zhenya Tang; Jianjun Zhang; Xinyan Lu; Wei Wang; Hui Chen; Melissa K Robinson; Joanne Cheng; Guilin Tang; L Jeffrey Medeiros
Journal:  Mod Pathol       Date:  2017-09-15       Impact factor: 7.842

2.  Section E9 of the American College of Medical Genetics technical standards and guidelines: fluorescence in situ hybridization.

Authors:  James T Mascarello; Betsy Hirsch; Hutton M Kearney; Rhett P Ketterling; Susan B Olson; Denise I Quigley; Kathleen W Rao; James H Tepperberg; Karen D Tsuchiya; Anne E Wiktor
Journal:  Genet Med       Date:  2011-07       Impact factor: 8.822

3.  Clinicopathological Characteristics of RET Rearranged Lung Cancer in European Patients.

Authors:  Sebastian Michels; Andreas Hans Scheel; Matthias Scheffler; Anne Maria Schultheis; Oliver Gautschi; Franziska Aebersold; Joachim Diebold; Georg Pall; Sacha Rothschild; Lukas Bubendorf; Wolfgang Hartmann; Lukas Heukamp; Hans-Ulrich Schildhaus; Jana Fassunke; Michaela Angelika Ihle; Helen Künstlinger; Carina Heydt; Rieke Fischer; Lucia Nogovà; Christian Mattonet; Rebecca Hein; Anne Adams; Ulrich Gerigk; Wolfgang Schulte; Heike Lüders; Christian Grohé; Ullrich Graeven; Clemens Müller-Naendrup; Andreas Draube; Karl-Otto Kambartel; Stefan Krüger; Susanne Schulze-Olden; Monika Serke; Walburga Engel-Riedel; Britta Kaminsky; Winfried Randerath; Sabine Merkelbach-Bruse; Reinhard Büttner; Jürgen Wolf
Journal:  J Thorac Oncol       Date:  2016-01       Impact factor: 15.609

4.  Detection of ROS1 gene rearrangement in lung adenocarcinoma: comparison of IHC, FISH and real-time RT-PCR.

Authors:  Ling Shan; Fang Lian; Lei Guo; Tian Qiu; Yun Ling; Jianming Ying; Dongmei Lin
Journal:  PLoS One       Date:  2015-03-05       Impact factor: 3.240

5.  RET-rearranged non-small-cell lung carcinoma: a clinicopathological and molecular analysis.

Authors:  K Tsuta; T Kohno; A Yoshida; Y Shimada; H Asamura; K Furuta; R Kushima
Journal:  Br J Cancer       Date:  2014-02-06       Impact factor: 7.640

Review 6.  Testing for ROS1 in non-small cell lung cancer: a review with recommendations.

Authors:  Lukas Bubendorf; Reinhard Büttner; Fouad Al-Dayel; Manfred Dietel; Göran Elmberger; Keith Kerr; Fernando López-Ríos; Antonio Marchetti; Büge Öz; Patrick Pauwels; Frédérique Penault-Llorca; Giulio Rossi; Aleš Ryška; Erik Thunnissen
Journal:  Virchows Arch       Date:  2016-08-17       Impact factor: 4.064

7.  Section E6.5-6.8 of the ACMG technical standards and guidelines: chromosome studies of lymph node and solid tumor-acquired chromosomal abnormalities.

Authors:  Linda D Cooley; Cynthia C Morton; Warren G Sanger; Debra F Saxe; Fady M Mikhail
Journal:  Genet Med       Date:  2016-04-28       Impact factor: 8.822

8.  Clinicopathological characteristics of ROS1- and RET-rearranged NSCLC in caucasian patients: Data from a cohort of 713 non-squamous NSCLC lacking KRAS/EGFR/HER2/BRAF/PIK3CA/ALK alterations.

Authors:  Frédéric Dugay; Francisco Llamas-Gutierrez; Marjory Gournay; Sarah Medane; François Mazet; Dan Christian Chiforeanu; Emmanuelle Becker; Régine Lamy; Hervé Léna; Nathalie Rioux-Leclercq; Marc-Antoine Belaud-Rotureau; Florian Cabillic
Journal:  Oncotarget       Date:  2017-06-08
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.